AIDS does not have a single recognizable appearance. Because it is defined by the collapse of the immune system rather than by one specific disease, its visible signs depend entirely on which opportunistic infections and cancers take hold as immune defenses fail. A person with AIDS might present with dramatic weight loss, purplish skin lesions, white patches coating the mouth, chronic diarrhea, or severe pneumonia, or with all of these at once. The diagnosis itself hinges on a specific threshold: an HIV-positive person whose CD4 immune cell count drops below 200 cells per microliter meets the case definition for AIDS, regardless of whether visible symptoms have appeared yet.
How AIDS Is Defined and Why Symptoms Vary So Widely
HIV slowly destroys CD4 T-cells, the immune cells that coordinate the body’s defense against infections. Without treatment, this process takes years. When the count falls below 200, the immune system is too weak to fend off organisms that a healthy body would easily suppress. These organisms, called opportunistic pathogens, cause the actual illnesses that people associate with AIDS. The CDC’s classification system formally defines AIDS by that CD4 threshold or by the appearance of any one of several dozen specific “AIDS-defining” conditions, from certain cancers to rare pneumonias.
This is why no two people with AIDS necessarily look the same. Someone living in a tropical region might develop severe parasitic diarrhea. Someone else might first notice painless purple spots on their skin. A third person might become confused and forgetful as infection reaches their brain. The common thread is an immune system too depleted to keep these threats in check.
Constitutional Symptoms and Swollen Lymph Nodes
Before AIDS-defining illnesses set in, the body often signals trouble with what clinicians call constitutional symptoms: persistent fevers, drenching night sweats, and fatigue that does not improve with rest. Data from the Multicenter AIDS Cohort Study found that more than 30% of HIV-positive participants had persistent generalized lymphadenopathy, meaning swollen lymph nodes in multiple body areas, and this occurred regardless of how low the CD4 count had fallen. Other signs like oral thrush (a white fungal coating in the mouth), anemia, and fever showed up at only modestly reduced CD4 counts (around 400 to 700 cells per microliter) and increased sharply as counts dropped further.1PubMed. Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study
These early signs are not specific to HIV; fevers and swollen glands accompany many infections. That is part of what makes HIV tricky to recognize without testing. But when the symptoms persist for weeks or months without another explanation, they can be a meaningful warning that immune function is deteriorating.
Skin and Oral Manifestations
Skin and mouth problems are among the most visible markers of advancing HIV disease, and they often appear before a person receives an AIDS diagnosis. Oral manifestations occur in up to half of all HIV-positive individuals and in up to 80% of those whose CD4 counts have dropped into the AIDS range.2PubMed Central. Oral Manifestations Associated with HIV/AIDS Patients The most commonly observed infections in one study of HIV-positive patients were oral candidiasis (about a third of cases), herpes zoster (the painful blistering rash also known as shingles, in about 13%), genital warts, and genital herpes. Among non-infectious skin problems, seborrheic dermatitis (a scaly, greasy rash typically affecting the face and scalp) and pruritic papular eruptions (itchy, raised bumps) were most frequent.3PubMed Central. Skin and Mucocutaneous Manifestations: Useful Clinical Predictors of HIV/AIDS
One older but still-cited study identified four clinical signs that predicted progression to AIDS with striking reliability: facial dermatitis, yellow toenail changes, oral hairy leukoplakia (white, corrugated patches on the sides of the tongue caused by Epstein-Barr virus), and oral candidiasis. One or more of these signs appeared in 93% of patients before they developed AIDS or a major opportunistic infection.4PubMed. Dermatitis of the face, yellow toe nail changes, hairy leukoplakia and oral candidiasis are clinical indicators of progression to AIDS/opportunistic infection in patients with HIV infection
Oral candidiasis specifically becomes much more likely once the CD4 count dips below 200. One study found the adjusted odds of oral candidiasis at that count were roughly 13 times higher compared to those with healthier immune function, while the odds of oral hairy leukoplakia were about 7 times higher.5PubMed. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults These oral changes are painless enough that some people ignore them, but they are among the most reliable visible clues that immunity is failing.
Wasting Syndrome
Severe, unintentional weight loss was once so strongly associated with AIDS that “slim disease” became a colloquial name for it in parts of sub-Saharan Africa. AIDS wasting syndrome, defined as the involuntary loss of more than 10% of body weight accompanied by chronic diarrhea or fever, remains an AIDS-defining condition. The person often looks gaunt, with sunken cheeks, protruding bones, and visibly reduced muscle mass.
This wasting is not simply starvation. Although reduced food intake plays a role, the metabolic picture of AIDS wasting more closely resembles cachexia, a state seen in cancer and sepsis. The body’s resting energy expenditure stays elevated rather than dropping as it would in simple calorie restriction. Protein turnover increases dramatically, lean tissue is preferentially lost over fat, and lipid metabolism shifts toward increased fat production even as the person shrinks. These metabolic abnormalities mean that just eating more does not reliably reverse the process.6The Journal of Nutrition. Wasting in HIV Infection and AIDS
Pneumocystis Pneumonia and Other Lung Infections
Pneumocystis jirovecii pneumonia, usually called PCP, was the infection that first alerted physicians to the AIDS epidemic in the early 1980s, and it remains one of the most common AIDS-defining diagnoses in the United States and Europe.7PubMed Central. HIV-associated Pneumocystis pneumonia It is caused by a fungus that healthy immune systems handle easily but that can be life-threatening when CD4 counts are very low.8PubMed Central. Pneumocystis jirovecii pneumonia in people living with HIV: a review
PCP typically presents with a dry cough that worsens over weeks, progressive shortness of breath, fevers, and a general feeling of being unwell. Unlike bacterial pneumonia, it tends to come on gradually rather than hitting all at once. Despite the availability of antiretroviral therapy and prophylactic antibiotics, PCP still occurs regularly in people who do not know they are HIV-positive, who have lost access to medical care, or who have stopped taking their medications.9PubMed Central. HIV-associated opportunistic pneumonias Tuberculosis is another major respiratory threat, particularly in parts of the world where TB is common. Both diseases can cause night sweats, weight loss, and persistent coughing, making them difficult to distinguish by symptoms alone.
Kaposi’s Sarcoma and Other Cancers
Kaposi’s sarcoma (KS) is probably the most visually distinctive sign of AIDS. It produces painless, raised or flat patches on the skin that range from purplish-red to brown-black, depending on the person’s skin tone. These lesions can appear anywhere: the face, legs, arms, mouth, and internal organs. KS is driven not by HIV itself but by a separate virus, human herpesvirus-8, and has become one of the most common skin cancers in people with AIDS.10Wiley Online Library. Kaposi’s sarcoma: aetiopathogenesis, histology and clinical features Prior to effective HIV treatment, KS was widespread; it is now far less common among people on antiretroviral therapy, but it still occurs.
Non-Hodgkin lymphoma is another AIDS-defining cancer. The most common and aggressive subtype is diffuse large B-cell lymphoma.11PubMed Central. Human Immunodeficiency Virus Related Non-Hodgkin’s Lymphoma Unlike KS, lymphoma is largely an internal disease and may not produce obvious visible changes on the skin. It often involves the abdomen; imaging studies of patients with AIDS-related non-Hodgkin lymphoma found intra-abdominal involvement in about two-thirds of cases, with the gastrointestinal tract, liver, and kidneys among the most frequently affected organs.12PubMed. AIDS-related non-Hodgkin’s lymphoma: abdominal CT findings in 112 patients A person with AIDS-related lymphoma might notice abdominal pain, swelling, unexplained fevers, or further weight loss.
Neurological and Cognitive Changes
HIV has a particular affinity for the brain. The virus replicates in certain brain cells, allowing it to persist in the central nervous system even when medications suppress it in the bloodstream. Over time, this can cause a spectrum of cognitive problems grouped under the term HIV-associated neurocognitive disorders. At the mild end, a person might notice trouble concentrating or remembering things. At the severe end lies HIV-associated dementia, which involves marked deficits in memory, attention, language, and motor skills, often leaving a person unable to manage daily activities without help.13The Microbe. HIV and dementia
HIV replication in the brain occurs primarily in astrocytes and microglia, immune-type cells that release inflammatory signals damaging to neurons. The resulting cognitive disturbances are linked both to the virus itself and to inflammation from these immune cells.14PubMed Central. Cognitive impairment in patients with AIDS – prevalence and severity In addition, opportunistic infections can target the brain directly. Toxoplasmosis, caused by a common parasite, is one of the most feared. It typically produces focal neurological deficits, meaning symptoms that affect one part of the body, like weakness on one side or difficulty speaking. Brain imaging characteristically shows ring-shaped lesions in deep brain structures.15PubMed Central. HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease
Cryptococcal meningitis, caused by a yeast-like fungus, is another severe brain infection in AIDS. It presents with headaches, confusion, neck stiffness, and sometimes vision changes. Compared to people who develop cryptococcal meningitis for other reasons, those with HIV tend to have higher levels of the fungus in their blood and spinal fluid, lower blood cell counts, and elevated pressure inside the skull.16PubMed Central. Cryptococcal Meningitis: Differences between Patients with and without HIV-Infection
Vision Loss
Cytomegalovirus (CMV) retinitis is the most common cause of vision loss in people with AIDS.17PubMed Central. Optimal management of cytomegalovirus retinitis in patients with AIDS CMV is a virus that most adults carry without any trouble, but when the immune system collapses, it can attack the retina. Early on, a person might notice floaters, flashing lights, or blurry patches in their visual field. Left untreated, CMV retinitis destroys retinal tissue and causes permanent blindness. Before combination antiretroviral therapy became widely available, CMV retinitis was extremely common in advanced AIDS; it is now seen far less frequently in places with good access to treatment, though it remains a threat whenever treatment fails or is unavailable.18PubMed. Cytomegalovirus Retinitis: A Review
Chronic Diarrhea and Gut Infections
Persistent diarrhea lasting weeks or months is one of the hallmarks of AIDS, especially in resource-limited settings. Cryptosporidium, a waterborne parasite that causes short-lived illness in healthy people, can produce relentless, watery diarrhea in people with AIDS that leads to severe dehydration and death. A systematic review found that Cryptosporidium infection significantly raises the risk of chronic diarrhea in people living with HIV, with low CD4 counts worsening the severity.19PubMed Central. Cryptosporidium Infection Increases the Risk for Chronic Diarrhea Among People Living With HIV in Southeast Asia: A Systematic Review and Meta-Analysis In people with healthy immune systems, cryptosporidiosis resolves on its own. In AIDS, the parasite can spread beyond the gut to the bile ducts and other organs, producing a more severe and potentially fatal illness.20PubMed Central. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients
Studies from Ethiopia have found Cryptosporidium in roughly a quarter of HIV-positive patients tested, with the infection strongly linked to diarrhea and vomiting.21PLOS Neglected Tropical Diseases. Distribution and Clinical Manifestations of Cryptosporidium Species and Subtypes in HIV/AIDS Patients in Ethiopia Other gut pathogens that take advantage of the weakened immune system include Mycobacterium avium complex, various microsporidial species, and CMV (the same virus that attacks the eyes). The result is often a cycle of malabsorption, diarrhea, and wasting that reinforces itself.
Disseminated Mycobacterial Infections
Mycobacterium avium complex (MAC), a group of bacteria related to the one that causes tuberculosis, can spread throughout the body when the immune system is severely depleted. Disseminated MAC is particularly dangerous at extremely low CD4 counts. In one comparative study, patients with disseminated MAC had a median CD4 count of just 5 cells per microliter, compared to 38.5 in those with tuberculosis. Their one-year mortality was roughly three times higher than that of patients with TB. Clinically, disseminated MAC and TB are hard to tell apart, as both can cause fever, cough, night sweats, and weight loss. However, MAC tended to occur in people with lower body mass and often lacked the chest X-ray abnormalities typically seen in TB.22PubMed. Disseminated Mycobacterium avium complex infection as a differential diagnosis of tuberculosis in HIV patients
How AIDS Looks in Children
Children who acquire HIV at birth or during breastfeeding can develop AIDS with a somewhat different set of visible signs. Growth failure is one of the most sensitive early indicators of disease progression. HIV-infected infants are often born smaller and lighter than uninfected infants born to the same mothers, and this growth deficit tends to worsen over time.23The Journal of Nutrition. Dysregulation of Growth and Development in HIV-Infected Children Poor growth is reported in as many as half of HIV-infected children, and the pattern is one of progressive stunting, with proportionate decreases in both height and weight, along with preferential loss of lean body mass.24PubMed. Growth failure in children with HIV infection
Children with AIDS also commonly develop recurrent bacterial infections, persistent oral thrush, chronic ear infections, and swollen parotid glands (the salivary glands in front of the ears, producing a characteristic “chipmunk” facial swelling). Developmental delays and failure to reach age-appropriate milestones can indicate neurological involvement. Because children normally grow rapidly, the visible impact of immune failure on their development tends to be more immediately obvious than the gradual wasting seen in adults.
Lipodystrophy and Treatment-Related Body Changes
Somewhat paradoxically, some of the most visible changes associated with HIV are caused not by the virus itself but by the medications used to treat it. HIV-associated lipodystrophy is a syndrome of fat redistribution that involves both loss and gain of fat in specific body areas. Fat melts away from the face, arms, legs, and buttocks (lipoatrophy), while accumulating in the belly, breasts, and the back of the neck, sometimes forming a visible hump. This combination creates a distinctive body shape that many patients find distressing.25PubMed Central. HIV-associated lipodystrophy: a review from a Brazilian perspective MRI studies have confirmed that the pattern of fat loss in lipoatrophy is distinct from the pattern seen in wasting or normal weight fluctuation, meaning clinicians can distinguish the two.26PubMed. Changes in facial fat in HIV-related lipoatrophy, wasting, and weight gain measured by magnetic resonance imaging
Lipodystrophy became a major concern in the era of early protease inhibitors and certain older nucleoside drugs. Newer antiretroviral regimens carry a lower risk, but the problem has not disappeared entirely, and people who developed lipodystrophy on older drugs may live with permanent facial and body changes.
When Treatment Itself Triggers New Symptoms
Starting antiretroviral therapy is lifesaving, but in some patients it produces a confusing phenomenon: symptoms get worse before they get better. This is called immune reconstitution inflammatory syndrome, or IRIS. As the recovering immune system regains strength, it mounts an aggressive inflammatory response against infections that were silently lurking. An existing infection might flare dramatically, or a previously unrecognized one might suddenly become apparent. IRIS can involve high fevers, swelling of lymph nodes, worsening skin lesions, or new neurological symptoms, depending on which underlying infection triggers the reaction.27PubMed Central. HIV & immune reconstitution inflammatory syndrome (IRIS)
IRIS is most common in people who start treatment with very low CD4 counts, precisely the group that most urgently needs therapy. The timing, usually within the first few weeks to months of treatment, helps distinguish IRIS from treatment failure. It resolves as the immune system stabilizes, but in the short term it can be alarming for patients and clinicians alike, and severe cases involving the brain or lungs can be dangerous.
Why the “Look” of AIDS Has Changed Over Decades
In wealthy countries with broad access to antiretroviral therapy, many of the dramatic AIDS-defining illnesses described above have become uncommon. A person diagnosed with HIV today who starts treatment promptly and takes it consistently may never develop any of these conditions. Their CD4 count stays above the danger zone, and opportunistic infections are kept at bay. This has fundamentally changed the visual reality of HIV: most people living with the virus in well-resourced settings look entirely healthy.
Where access to treatment is limited, delayed, or interrupted, however, AIDS still looks much as it did in the 1980s and 1990s. Wasting, Kaposi’s sarcoma, PCP, chronic diarrhea, and oral candidiasis remain everyday realities in parts of sub-Saharan Africa, Southeast Asia, and other regions with high HIV prevalence and fragmented healthcare systems. Even in wealthy countries, people who are unaware of their infection, who face barriers to care, or who stop taking their medications can present with advanced disease and the full spectrum of AIDS-defining illnesses. The visual signs of AIDS have not been eliminated; they have been redistributed along lines of access and awareness.